Unknown

Dataset Information

0

Magnolol dimer-derived fragments as PPAR?-selective probes.

ABSTRACT: Partial agonists of the transcription factor PPAR? (peroxisome proliferator-activated receptor ?) have shown potential for the treatment of metabolic and inflammatory conditions and novel activators serve as valuable tool and lead compounds. Based on the natural product magnolol (I) and recent structural information of the ligand-target interaction we have previously developed magnolol dimer (II) which has been shown to have enhanced affinity towards PPAR? and improved selectivity over RXR? (retinoid X receptor ?), PPAR?'s heterodimerization partner. In this contribution we report the synthesis and evaluation of three fragments of the dimeric lead compound by structural simplifications. Sesqui magnolol A and B (III and IV) were found to exhibit comparable activities to magnolol dimer (II) and selectivity over RXR? persisted. Computational studies suggest a common pharmacophore of the distinctive biphenyl motifs. Truncated magnolol dimer (V) on the other hand does not share this feature and was found to act as an antagonist.

SUBMITTER: Dreier D 

PROVIDER: S-EPMC6180429 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Magnolol dimer-derived fragments as PPARγ-selective probes.

Dreier Dominik D   Resetar Mirta M   Temml Veronika V   Rycek Lukas L   Kratena Nicolas N   Schnürch Michael M   Schuster Daniela D   Dirsch Verena M VM   Mihovilovic Marko D MD  

Organic & biomolecular chemistry 20181001 38

Partial agonists of the transcription factor PPARγ (peroxisome proliferator-activated receptor γ) have shown potential for the treatment of metabolic and inflammatory conditions and novel activators serve as valuable tool and lead compounds. Based on the natural product magnolol (I) and recent structural information of the ligand-target interaction we have previously developed magnolol dimer (II) which has been shown to have enhanced affinity towards PPARγ and improved selectivity over RXRα (ret  ...[more]

Similar Datasets

Unknown Linked magnolol dimer as a selective PPAR? agonist - Structure-based rational design, synthesis, and bioactivity evaluation.
| S-EPMC5651862 | biostudies-literature
Unknown Sensitive luciferin derived probes for selective carboxypeptidase activity.
| S-EPMC3129288 | biostudies-literature
Unknown Magnolol Prevents Acute Alcoholic Liver Damage by Activating PI3K/Nrf2/PPAR? and Inhibiting NLRP3 Signaling Pathway.
| S-EPMC6915046 | biostudies-literature
Unknown Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants.
| S-EPMC7472585 | biostudies-literature
Unknown Selective PPAR-Delta/PPAR-Gamma Activation Improves Cognition in a Model of Alzheimer's Disease.
| S-EPMC10136457 | biostudies-literature
Unknown Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) ? activators and pan-PPAR partial agonists.
| S-EPMC3359336 | biostudies-literature
Unknown Signaling Mechanisms of Selective PPAR? Modulators in Alzheimer's Disease.
| S-EPMC6215547 | biostudies-other
Unknown Thymine dimer-induced structural changes to the DNA duplex examined with reactive probes (†).
| S-EPMC2891882 | biostudies-literature
Unknown Self-Assembling NanoLuc Luciferase Fragments as Probes for Protein Aggregation in Living Cells.
| S-EPMC5110118 | biostudies-literature
Unknown Skin-targeted inhibition of PPAR ?/? by selective antagonists to treat PPAR ?/?-mediated psoriasis-like skin disease in vivo.
| S-EPMC3351437 | biostudies-literature